
    
      Subjects will receive standard treatment for autologous stem cell transplant. Subjects will
      be assigned to receive no Eltrombopag or one of three dose levels of Eltrombopag. Subjects
      will receive oral Eltrombopag on days 2-15 of treatment.
    
  